PET imaging of 5-HT1A receptors can evaluate mild neurodegenerative changes in AD [66] and lower 5-HT levels may be associated with poorer prognoses, such as cognitive decline and worsening emotional symptoms in both AD and PD patients. This evidence concerns the gene HTR1A and Alzheimer disease.